1. Home
  2. YMT vs BDRX Comparison

YMT vs BDRX Comparison

Compare YMT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yimutian Inc. American Depositary Shares

YMT

Yimutian Inc. American Depositary Shares

HOLD

Current Price

$1.91

Market Cap

1.3M

Sector

Technology

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$0.79

Market Cap

1.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
BDRX
Founded
2011
2000
Country
China
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
1.6M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
YMT
BDRX
Price
$1.91
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.3M
243.7K
Earning Date
06-09-2026
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.60
52 Week High
$3.45
$11.88

Technical Indicators

Market Signals
Indicator
YMT
BDRX
Relative Strength Index (RSI) 66.60 19.48
Support Level $0.22 $0.60
Resistance Level $2.07 $1.50
Average True Range (ATR) 0.21 0.14
MACD 0.21 -0.01
Stochastic Oscillator 54.39 4.41

Price Performance

Historical Comparison
YMT
BDRX

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc operates an agricultural B2B platform in China. It provides a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching and matching to transaction facilitation and settlement, through its Yimutian App and Douniu App. Additionally, leveraging its industry experience and market insights, the company has ventured into the realm of smart farming and agricultural sourcing and trading, further broadening its commercialization channels and animating its other business lines. The company operates as a single operating and reportable segment, as it offers a unified set of products and services mainly related to the provision of digital agricultural transaction services.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: